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Collagen synthesis is a complex orchestration of intra­
cellular and extracellular events. In addition to synthesis 
of the polypeptide chains more than a dozen modifica­
tions of the molecule occur; most of these are enzymatic 
and specific for collagen. Regulational control of colla­
gen synthesis promises to be equally complex. Examples 
are described to 4 specific regulatory influences. Ascor­
bic acid markedly stimulates collagen synthesis without 
affecting synthesis of other proteins. This effect appears 
to be unrelated to its cofactor roles for hydroxylation of 
lysine and proline. Glucocorticoids at J-tM concentration 
specifically inhibit collagen synthesis. Tissues treated 
with glucocorticoids have diminished levels of mRNA 
for collagen. During collagen synthesis the aminoter­
minal propeptide of procollagen is cleaved by a specific 
protease. This peptide appears to be a feedback inhibitor 
of collagen synthesis. This effect can be demonstrated in 
cells and in cell-free synthesizing systems. A membrane 
receptor system may permit the peptide to be recognized 
and subsequently act as a translational control mecha­
nism. Viral transformation of fibroblasts results in selec­
tively decreased synthesis of collagen. Levels of cyto­
plasmic and nuclear mRNA are likewise selectively di­
minished consistent with transcriptional control. 
The regulation of collagen synthesis promises to be complex 
since many post-translational modifications are necessary for 
the synthesis of the final product. In addition the simultaneous 
synthesis of several species of collagen must be orchestrated at 
the cellular leveL Thus regulation could be operational at many 
levels of synthesis. These include gene selection, transcription, 
messenger splicing, translation, hydroxylation of proline and 
lysine, glycosylation of hydroxylysine, glycosylation of propep­
tides, helix formation, translocation, secretion, cleavage of pro­
peptides, fibril formation, cross linking, intracellular and extra­
cellular degradation, and aging modifications. Many environ­
mental factors, hormones, drugs, vitamins, minerals and other 
substances have been reported to influence collagen production 
[review, reference 1]. A comprehensive review is beyond the 
scope of this manuscript. Instead I have chosen 4 representative 
regulation systems in which specific effects on collagen synthe­
sis have been clearly established. 
Although regulation studies have been carried out in whole 
animals, organ culture, primary, and continuous cell culture, as 
well as cell-free systems each has its advantages and disadvan­
tages. 
Human skin fibroblasts in culture are convenient for studying 
cellular regulation. Although not immortal, these cells can be 
studied through 30 or more replications. The amount of collagen 
synthesized by these cells is appreciably greater than continu­
ous fibroblast lines and with proper attention to culture condi­
tions [2,3] relative collagen synthesis approaches that achieva­
ble in primary cell culture. 
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Certain disadvantages in using human skin fibroblasts in 
collagen regulation experiments need to be understood. Human 
skin fibroblasts in culture are a heterogenous population of 
cells. Although growth characteristics of fibroblasts explanted 
from papillary and reticular dermis are different, relative col­
lagen synthesis and qualitative collagen synthesis are similar 
[4]. Relative collagen synthesis is cell density dependent and is 
only maximal at confluent densities [2]. 
In order to carry out regulatory experiments it would be 
desirable to have a chemically defined media. Growth of human 
skin fibroblasts has not been achieved in serum-free media 
although cells can be maintained at a stable density in 0.5% 
dialyzed calf serum for many days. Human skin fibroblasts 
synthesize several types of collagen including types I, III, and 
V [4]. Although this may be an advantage for studying type­
specific or linked regulation, it could be a disadvantage for 
other studies. 
Collagen synthesis in most studies has been measured by 
determination of hydroxyproline or digestion with purified clos­
tridial collagenase [2]. When hydroxyproline is used to measure 
collagen it is assumed that hydroxylation of proline is stable. 
Since relative hydroxylation of proline could be a variable in 
regulatory systems, determination of collagen synthesis inde­
pendent of hydroxylation is desirable. Collagenase digestion has 
been demonstrated to be a reliable technique for the measure­
ment of collagen if care is taken to inhibit nonspecific proteo­
lytic activity [2]. 
SPECIFIC STIMULATION OF COLLAGEN SYNTHESIS 
BY ASCORBIC ACID 
That ascorbic acid is essential for collagen synthesis has been 
known for years and is evident from the well-known connective 
tissue disturbances that occur in scurvy. Its importance in 
hydroxylation of proline to form hydroxyproline and hydrox­
ylation of lysine to form hydroxylysine have been thought to 
account for its primary influence [5]. Since hydroxyproline is 
essential for collagen helix formation [6] and subsequent cellu­
lar secretion [7] and hydroxylysine is essential for collagen 
intermolecular crosslinking [8], inadequate levels of ascorbate 
might be expected to interfere with normal collagen production. 
Recently, however, it has become apparent that ascorbate has 
a specific primary stimulatory effect on collagen synthesis, one 
that is apparently unrelated to hydroxylation [9,10]. 
In confluent human skin fibroblasts ascorbate was capable of 
markedly stimulating total collagen synthesis without influenc­
ing noncollagen protein synthesis. Maximal stimulation oc­
curred at L-ascorbic acid levels as low as 30 flM (Fig 1) and the 
effect steadily increased for at least 4 days (Fig 2). During this 
interval collagen synthesis was stimulated fourfold and relative 
collagen synthesis was boosted from 9% to 32% of total protein 
synthesis (Fig 3). These levels are appreciably higher than 
those usually achieved in human skin fibroblast culture and 
represent the results that can be achieved when culture condi­
tions are maximized. 
Quite surprisingly levels of prolyl hydroxylase activity were 
diminished although lysyl hydroxylase activity increased under 
the influence of ascorbate [11]. The ascorbate stimulation of 
collagen synthesis appears not to be related to hydroxylation 
because relative hydroxylation of lysine in collagen synthesized 
by skin fibroblasts in the presence and absence of ascorbate was 
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FIG 1. The effect of L-ascorbic acid on collagen synthesis. Human 
skin fibroblasts at confluent density were exposed to L-ascorbic acid 
for a total of 72 hr. Fresh ascorbate was added each day. Cells were 
pulse labeled the final 6 hr with [2,3-IH1L-proline. The 
'
radioactivity 
incorporated into collagen and noncollagen protein was determined 
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FIG 2. The effect of time on the stimulation by L-ascorbic acid of 
collagen synthesis. Human skin fibroblasts at confluent density were 
exposed for varying times to 100 /LM L-ascorbic acid. All cultures were 
pulse labeled the final 6 hr with [2,3-'Hl-L-proline. The radioactivity 
incorporated into collagen and noncollagen protein was determined 
after digestion with clostridial collagenase. 
lowered in the absence of ascorbate, it was unchanged once 
ascorbate was present despite the continued increase in relative 
collagen synthesis and decline in prolyl hydroxylase activity 
[9]. Although the level of regulation of the ascorbate effect is 
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not understood, it required a confluent cellular density [6] and 
could be demonstrated in the presence of dialyzed calf serum 
from 0.5% to 20% concentration (Pinnell SR: unpublished ob­
servations). 
SPECIFIC INHIBITION OF COLLAGEN SYNTHESIS 
BY GLUCOCORTICOIDS 
Although quite effective as therapeutic agents, the clinical 
use of glucocorticoids is tempered by undesirable side effects. 
Many of these are related to connective tissue and include 
growth retardation, cutaneous atrophy, osteoporosis and re­
tarded wound healing. Although a selective effect on collagen 
synthesis has been suspected, unequivocal experimental evi­
dence has been difficult to accumulate. Many earlier studies 
measured the effect of glucocorticoids on hydroxyproline ac­
cumulation but these effects could have resulted from under­
estimation of collagen synthesis resulting from inhibition of 
prolyl hydroxylase activity by glucocorticoids [12,13] and sub­
sequent synthesis of underhydroxylated collagen. The most 
convincing studies have been carried out in human skin fibro­
blasts in which the synthesis of collagen was selectively de­
creased over that of noncollagen protein [14-16]. In these 
studies however the amount of protein synthesis devoted to 
collagen was small. 
Since ascorbate-stimulated cells devote appreciably more 
protein synthesis to collagen we studied the specific effects of 
glucocorticoids on collagen synthesis in association with ascor­
bate stimulation. Figure 4 shows the effect of hydrocortisone 
valerate at varying concentrations on synthesis of collagen and 


















FIG 3. The effect of L-ascorbic acid on relative collagen synthesis. 
Data obtained in the experiment shown in Fig 2 was analyzed by a 
formula which takes into account the relative abundance of proline in 
collagen in comparison to other proteins [2]. 
July 1982 
as glucocorticoid for 3 days. Collagen synthesis was slightly 
increased at 10-9 M. Similar increases were observed with dex­
amethasone and fluocinonide. Striking inhibition of collagen 
synthesis was observed at higher concentrations. N oncollagen 
protein synthesis remained relatively unchanged. When fibro­
blasts were exposed to hydrocortisone valerate (1 P.M) over 3 
days relative collagen synthesis decreased from 34% to 17% (Fig 
5). Similar results were observed with dexamethasone and 
fluocinonide. Thus glucocorticoids at low concentration specif­
ically and dramatically diminished collagen synthesis while 
having no effect on noncollagen protein synthesis. 
Rokowski, Sheehy and Cutroneo further examined the effect 
of glucocorticoids on collagen biosynthesis [17). They prepared 
ribosomes from skin and lung of control rats and rats injected 
with triamcinolone. In a cell free wheat germ translation system 
they demonstrated a selective reduction in collagen synthesis 
on membrane-bound polysomes from glucocorticoid-treated an­
imals. These studies further support a selective effect of gluco­
corticoids on collagen synthesis which can be demonstrated at 
the level of mRNA. 
CONTROL OF COLLAGEN SYNTHESIS BY AMINO­
TERMINAL EXTENSION PEPTIDES 
Feedback inhibition of collagen synthesis has been recently 
demonstrated by the globular portion of amino-terminal exten­
sion pro pep tides of pro collagen. Peptides derived from the 
amino terminal regions of type I and III calf pro collagens spe­
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FIG 4. The effect of hydrocortisone valerate on collagen synthesis. 
Human skin fibroblasts were incubated for 72 hr with varying concen­
trations of hydrocortisone valerate and 100 liM L-ascorbic acid . The 
media was changed daily. All cultures were pulse labeled the final (; hr 
with [2,3-"H] L-proline . The radioactivity incorporated into collagen 
and non collagen protein was determined after digestion with clostridial 
collagenase. 
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FIG 5. The effect of hydrocortisone valerate on collagen synthesis. 
Human skin fibroblasts at confluent density were exposed to 100 liM L­
ascorbic acid for 72 hr and 1 liM hydrocortisone valerate for varying 
intervals. All cultures were pulse labeled the final (; hr with [2,3-1Hl L­
proline. The radioactivity incorporated into collagen and noncollagen 
protein was determined after digestion with clostridial collagenase . 
fibroblast culture without affecting synthesis of other proteins 
[18). Types I and III propeptides were equally inhibitory for 
type I pro collagen synthesis; type III procollagen synthesis was 
not measured. The effect was specific since peptides prepared 
from the helical region of the collagen molecule were incapable 
of exerting the effect. The type I pro peptide was prepared from 
dermatosparactic calf skin and was derived from the pro 0'1 (I) 
chain; its molecular weight was 10,700 daltons. The type III 
propeptide was prepared from fetal calf skin and had a molec­
ular weight of 45,000 daltons. These results support previous 
observations in fibroblasts derived from patients with type VII 
Ehlers-Danlos syndrome in which conversion of procollagen to 
collagen was defective. Procollagen synthesis in these fibro­
blasts was markedly increased [19). 
The peptides were also capable of inhibiting procollagen 
synthesis in a cell free synthesizing system [20). Synthesis of 
pro 0'1 (I) and pro O'AI) by rat calvarial mRNA in a reticulocyte 
lysate was specifically inhibited by the propeptides but not by 
collagen helical peptides. The propeptides had little effect on 
translation of mRNAs for globin and rat liver vitellogenin. 
The effect of the propeptides on type II collagen synthesis 
was more complex [21). The type I propeptide was capable of 
inhibiting type II procollagen synthesis by chick sternal mRNA 
in a reticulocyte lysate. The type III propeptide however had 
no effect. The type I propeptide on the other hand was incap­
able of inhibiting type II pro collagen synthesis when added to 
chick sternal chondrocytes or fetal calf chondrocytes in culture. 
In addition no effect was demonstrated on chondrocytes allowed 
to dedifferentiate to produce predominantly type I collagen or 
on pro collagen synthesis by chick tendon fibroblasts. The data 
supports a specific translational control for these peptides in 
pro collagen synthesis. Cellular access may be limited by a 
specific recognition of the pro peptide by the cell. 
REGULATION OF COLLAGEN SYNTHESIS BY VIRAL 
TRANSFORMATION 
Perhaps the best studied system with respect to regulation of 
collagen synthesis is viral transformation. When fibroblasts are 
transformed by tumor virus a number of changes occur. These 
include alterations in cellular growth, adhesive properties, cel­
lular shape and synthesis of discrete proteins. Although synthe­
sis of most proteins is unaltered, synthesis of type I collagen is 
markedly diminished [22-25). Moreover the level of collagen 
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synthesis appears to be related to the degree of transformation 
[26]. 
The availability of cloned cDNA for chick pro al(l) and pro 
aAI) has made it possible to measure by hybridization tech­
niques the levels of mRNA specific for collagen. In chick embryo 
fibroblasts transformed with Rous sarcoma virus both total and 
nuclear collagen mRNA were about 5-fold lower than levels in 
normal cells [27,28]. Moreover, the changes were similar for 
mRNA specific for pro adI) and pro a2(1) i.e. mRNA levels for 
the two type I collagen chains were coordinately regulated. 
Using a strain of Rous sarcoma virus containing a temperature 
sensitive mutation in the pp 60"" gene, this transformation 
effect on transcription of collagen genes could be shown to be 
related to the pp 60"'c protein kinase [28]. 
Avvedimento et al prepared genomic pro a2(1) DNA clones 
containing introns and used these to specifically measure nu­
clear RNA for pro a2(I) [29]. In chick embryo fibroblasts 
infected with Rous sarcoma virus they were able to demonstrate 
a marked reduction in primary transcript mRNA for pro a2(1) 
suggesting a primary transcriptional control of type I collagen 
formation following transformation. Thus transcriptional con­
trol of collagen synthesis is an important result of cellular 
transformation and may be critical for maintaining the trans­
formed state. 
Although regulation of collagen synthesis promises to be 
complex, tools are now becoming available to understand these 
changes at a molecular level. 
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